Department of Molecular Medicine and Surgery, Section of Urology, Karolinska Institutet, Stockholm, Sweden,Karolinska Inst, Dept Mol Med & Surg, Sect Urol, Stockholm, Sweden.,Department of Medical Epidemiology and Biostatistics (MEB)
Franck Lissbrant, Ingela, 1969 (författare)
Gothenburg University,Göteborgs universitet,Institutionen för kliniska vetenskaper, Avdelningen för onkologi,Institute of Clinical Sciences, Department of Oncology,Department of Oncology Institute of Clinical Sciences, the Sahlgrenska Academy, University of Göteborg, Göteborg, Sweden,Univ Göteborg, Sahlgrenska Acad, Dept Oncol Inst Clin Sci, Gothenburg, Sweden.
Ahlgren, Johan (författare)
Regional Cancer Centre, Uppsala/Örebro, Uppsala University Hospital, Uppsala, Sweden,Uppsala Univ Hosp, Reg Canc Ctr, Uppsala, Sweden.
Bratt, Ola, 1963 (författare)
Gothenburg University,Göteborgs universitet,Institutionen för kliniska vetenskaper, Avdelningen för urologi,Institute of Clinical Sciences, Department of Urology,Department of Urology, Institute of Clinical Science, the Sahlgrenska Academy, Gothenburg University, Sweden; Department of Urology, Sahlgrenska University Hospital, Gothenburg, Sweden,Gothenburg Univ, Sahlgrenska Acad, Inst Clin Sci, Dept Urol, Gothenburg, Sweden.;Sahlgrens Univ Hosp, Dept Urol, Gothenburg, Sweden.
Lambe, M (författare)
Regional Cancer Centre, Uppsala/Örebro, Uppsala University Hospital, Uppsala, Sweden,Uppsala Univ Hosp, Reg Canc Ctr, Uppsala, Sweden.,Department of Medical Epidemiology and Biostatistics (MEB)
Introduction The first case of COVID-19 in Sweden was diagnosed in late January 2020, the first recommendations against the spread of the virus were released in mid-March, and the peak of the first wave of the pandemic was reached in March-June. The aim of this cross-sectional study was to assess the short-term effects of the first wave of the COVID-19 pandemic on prostate cancer (PCa) diagnosis, staging, and treatment. Materials and methods Data in the National Prostate Cancer Register (NPCR) of Sweden on newly diagnosed PCa cases and on the number of diagnostic and therapeutic procedures performed between 18 March 2020 and 2 June 2020 were compared with those in the corresponding time periods in 2017-2019, as reported until January 31 of the year after each study period. Results During the study period in 2020, 36% fewer PCa cases were registered in NPCR compared with the corresponding time period in previous years: 1458 cases in 2020 vs a mean of 2285 cases in 2017-2019. The decrease in new PCa registrations was more pronounced in men above age 75 years, down 51%, than in men aged 70-75, down 37%, and in men below age 70, down 28%. There was no decrease in the number of radical prostatectomies and number of radical radiotherapy courses increased by 32%. Conclusions During the peak of the first phase of the COVID-19 pandemic, the number of men diagnosed with PCa in Sweden decreased by one third compared with previous years, whereas there was no decrease in the number of curative treatments.
Ämnesord
MEDICIN OCH HÄLSOVETENSKAP -- Klinisk medicin -- Njurmedicin (hsv//swe)
MEDICAL AND HEALTH SCIENCES -- Clinical Medicine -- Nephrology (hsv//eng)
MEDICIN OCH HÄLSOVETENSKAP -- Klinisk medicin -- Cancer och onkologi (hsv//swe)
MEDICAL AND HEALTH SCIENCES -- Clinical Medicine -- Cancer and Oncology (hsv//eng)
MEDICIN OCH HÄLSOVETENSKAP -- Klinisk medicin (hsv//swe)
MEDICAL AND HEALTH SCIENCES -- Clinical Medicine (hsv//eng)
MEDICIN OCH HÄLSOVETENSKAP -- Medicinska och farmaceutiska grundvetenskaper -- Epidemiologi (hsv//swe)
MEDICAL AND HEALTH SCIENCES -- Basic Medicine -- Epidemiology (hsv//eng)
MEDICIN OCH HÄLSOVETENSKAP -- Hälsovetenskap -- Hälso- och sjukvårdsorganisation, hälsopolitik och hälsoekonomi (hsv//swe)
MEDICAL AND HEALTH SCIENCES -- Health Sciences -- Health Care Service and Management, Health Policy and Services and Health Economy (hsv//eng)